ArticleWorld journal of gastroenterology2009
Sclerosing epithelioid fibrosarcoma of the liver infiltrating the inferior vena cava.
Article in World journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 36 citations in OpenAlex.
- Sclerosing epithelioid fibrosarcoma associated with WRN gene variant presenting as chronic dyspnea and pathologic cervical fracture: a case report and review of the literature.Journal of medical case reports · 2023Review
- Response to Immunotherapy in Sclerosing Epithelioid Fibrosarcoma: Case Report and Literature Review.Cureus · 2023Article
- Sclerosing epithelioid fibrosarcoma of the kidney.BMJ case reports · 2023Article
- Metastatic pediatric sclerosing epithelioid fibrosarcoma.Cold Spring Harbor molecular case studies · 2021Review
- First description of hematogenously metastasized sclerosing epithelioid fibrosarcoma arising in the uterine cervix.Gynecologic oncology reports · 2021Article
- Sclerosing epithelioid fibrosarcoma of bone: morphological, immunophenotypical, and molecular findings of 9 cases.Virchows Archiv : an international journal of pathology · 2021Article
- Sclerosing epithelioid mesenchymal neoplasm of the pancreas - a proposed new entity.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020Article
- Liver resection combined with inferior vena cava resection and reconstruction using artificial vascular graft: A literature review.Annals of gastroenterological surgery · 2018Article
- Sclerosing Epithelioid Fibrosarcoma of the Coccyx: A Case Report and Review of Literature.Cureus · 2018Article
- Skull sclerosing epithelioid fibrosarcoma: A case report and review of the literature.Oncology letters · 2016Article
- Primary sclerosing epithelioid fibrosarcoma of kidney with variant histomorphologic features: report of 2 cases and review of the literature.Diagnostic pathology · 2015Review
- ¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma.International journal of clinical and experimental pathology · 2014Review
- Sclerosing epithelioid fibrosarcoma of the oral cavity.Head and neck pathology · 2011Article
- Article
- Sclerosing epithelioid fibrosarcoma metastasizing to the penile shaft.Canadian Urological Association journal = Journal de l'Association des urologues du CanadaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sclerosing epithelioid fibrosarcoma (SEF) is a rare and distinct variant of fibrosarcoma, composed of epithelioid tumor cells arranged in strands, nests, cords, or sheets embedded within a sclerotic collagenous matrix. We report a 39-year-old man with SEF of the liver, which infiltrated the inferior vena cava (IVC). The SEF of the liver was successfully resected, and the infiltrated IVC was also removed together with the liver tumor. Histopathological examination of the tumor showed typical histopathology of SEF. Immunohistochemically, the tumor was positive for vimentin. Recurrence was noted 7 mo after surgery. After chemotherapy, the recurrent tumor was resected surgically, and histopathological examination showed similar findings to those of the primary tumor. To our knowledge, this is the first report of SEF of the liver with tumor invasion of the IVC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.